I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Linzhao Cheng, Ph.D.
Edythe Harris Lucas and Clara Lucas Lynn Chair in Hematology
Professor of Medicine
Research Interests: Stem cell models for hematopoiesis; iPS cell models; genome editing and engineering; blood disease modeling
Linzhao Cheng, PhD, the Edythe Harris Lucas and Clara Lucas Lynn Professor of Hematology, is a professor of medicine, oncology and gynecology/obstetrics. He is a founding member of the Stem Cell Program in the Institute for Cell Engineering, Johns Hopkins University School of Medicine. Dr. Cheng is also the associate director for basic research in the Division of Hematology and a member of the Johns Hopkins Kimmel Cancer Center. Cheng received his Ph.D. in molecular biology and genetics from The Johns Hopkins University in 1991 and joined its faculty in 1999.
While a doctoral student, Dr. Cheng worked on human DNA replication models and transcriptional factors, including one of the first two DNA-binding proteins from mammalian cells (NF-I/CTF). He initiated his stem cell research career as a postdoctoral fellow, helping establish mouse pluripotent stem cell lines from primordial germ cells, a landmark study published in Nature in 1992. Since 1994, his research has focused on human stem cell biology and cell engineering. Dr. Cheng led groups within the industry and at Johns Hopkins and has published more than 78 original research papers, including those in Nature Biotechnology, Nature Medicine, Nature Genetics, Cell, Stem Cell, Blood, and Proceedings of the National Academy of Sciences. His lab is currently focused on using human stem cells for blood disease modeling and treatment.
Dr. Cheng's involvement in stem cell research has included investigations at the National Institutes of Health (NIH), in the biotech industry, and as a faculty member at Johns Hopkins. He was the recipient of the USA Presidential Early Career Award for Scientists and Engineers in 2003. In 2012, Dr. Cheng was elected as a fellow of American Association for Advancement of Sciences (AAAS). Dr. Cheng also received an award in 2004 from National Natural Sciences Foundation of China (NSFC) to promote international collaborations. He has served frequently as a reviewer/adviser for granting agencies including the NIH, NSF (USA), Cancer Research UK, Canada FFI, Swiss NSF, NSFC, and STCSM (Shanghai) and as an editorial board member for Stem Cells (USA), Regenerative Medicine (UK), and Cell Research (China). Dr. Cheng is a member of the International Affairs Committee for the International Society for Stem Cell Research (ISSCR), the Stem Cell Policy and Ethics (SCoPE) Program at The Johns Hopkins University, and the (international) Hinxton Group focusing on stem cell policies and ethics.
- Edythe Harris Lucas and Clara Lucas Lynn Chair in Hematology
- Associate Director for Basic Research
- Member, Stem Cell Program in the Institute of Cell Engineering
- Professor of Medicine
- Professor of Gynecology and Obstetrics
- Professor of Oncology
- Ph.D., Johns Hopkins University School of Medicine (Maryland) (1991)
Research & Publications
The Cheng lab studies human stem cell biology and engineering to develop experimental models of and treatments for human blood diseases. The team has made several discoveries in understanding human stem cell self-renewal and hematopoietic (blood-forming) differentiation using adult hematopoietic stem cells and human pluripotent stem cells. They also poineered recently efficient methods to establish human induced pluripotent stem (iPS) cells from both blood cells and fibroblasts by plasmids without integrating into cellular chromosomes. In effort to develop better genetic models and gene therapy methods, the Cheng lab develops new methods for making genetic modifications in human cells using various methods such as human genome editing.
Dr. Cheng's main laboratory is working on human stem cell biology and engineering, and their applications in regenerative medicine for curing blood diseases. One of their objectives is to understand genetic and epigenetic regulation of cell fate determination in hematopoiesis. The group currently focuses on using human pluripotent stem such as iPS cells from healthy donors and patients. They use both cellular differentiation and genetic approaches such as genome editing to orrect or create mutations in human stem cells. Their goals is to investigate human stem cell biology and diseases. More details are available on his lab website www.stemcelllab.org
Lab Website: Cheng Laboratory
Technology Expertise KeywordsStem cell biology, Human iPS cells and reprogramming, human genome engineering, genome editing
Clinical TrialsNone at this moment
Selected PublicationsView all on Pubmed
Cheng L†, Fu J, Tsukamoto A, Hawley RG. Use of green fluorescent protein (GFP) variants to monitor gene transfer and expression in mammalian cells. Nature Biotechnology. 1996; 14: 606-609. († Corresponding author).
Cui Y, Golob J, Kelleher E, Ye Z, Pardoll D, Cheng L. Targeting transgene expression to antigen presenting cells derived from lentivirus transduced, engrafting human hematopoietic stem/progenitor cells. Blood. 2002; 99: 399-408.
Zou J, Maeder ML, Mali P, Pruett-Miller SM, Thibodeau-Beganny S, Chou BK, Chen G, Ye Z, Park IH, Daley GQ, Porteus MH, Joung JK, Cheng L. Gene targeting of a disease-related gene in human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell. 2009; 5:97-110.
Ye Z, Zhan H, Mali P, Dowey S, Jang Y-Y, Dang CV, Spivak JL, Moliterno AR, Cheng L. Human induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood. 2009; 114:5473-5480.
Chou BK, Mali P, Huang X, Ye Z, Dowey SN, Resar LMS, Zou C, Zhang YA, Tong J and Cheng L. Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Research, 2011; 21(3):518-29.
Activities & Honors
- Fellow, American Association for Advancement of Sciences (AAAS), 2012
- Presidential Early Career Award for Scientists and Engineers (PECASE), 2003
- National Natural Sciences Foundation of China (NSFC), 2004
- International Affairs Committee, International Society for Stem Cell Research (ISSCR)
- Reviewer/Adviser, NIH
- Reviewer/Adviser, NSF
- Reviewer/Adviser, Cancer Research UK
- Reviewer/Adviser, Canada FFI
- Reviewer/Adviser, Swiss NSF
- Reviewer/Adviser, NSFC
- Reviewer/Adviser, STCSM
- Study section on Molecular and Cellular Hematology, NIH, 2011
Videos & Media
Recent News Articles and Media Coverage
- Three Johns Hopkins Researchers Named AAAS Fellows
- Human Embryonic Stem Cell Research Reveals Earliest Step in Human Development
- Improved Adult-Derived Human Stem Cells Have Fewer Genetic Changes Than Expected
- Johns Hopkins Researchers Develop Safer Way to Make Induced Pluripotent Stem Cells
- Johns Hopkins Researchers Edit Genes in Human Stem Cells
- Johns Hopkins Researchers Develop Human Stem Cell Line Containing Sickle Cell Anemia Mutation
- Engineered Blood
- Human Stem Cell Research: Stepping It Up a Notch